Levodopa Benserazide Teva

Levodopa and Benserazide, the active ingredient in Levodopa Benserazide Teva, is an antiparkinson agent presented as an oral tablet for oral use. It is employed to manage the motor symptoms of Parkinson's disease and related Parkinsonian syndromes in adult patients.

GNH USA supplies Levodopa Benserazide Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards, provides regulatory documentation, and offers reliable logistics for global distribution. Customers benefit from consistent supply and technical support.

Levodopa + Benserazide is used in the management of Parkinsonian disorders, acting on central dopaminergic pathways. - Parkinson's disease: improves motor function, reduces rigidity and bradykinesia. - Parkinsonian syndrome: alleviates symptoms caused by drug‑induced or secondary Parkinsonism. - Rest tremor: diminishes tremor amplitude and frequency.

Levodopa + Benserazide may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Orthostatic hypotension: dizziness upon standing. - Headache: transient cranial discomfort. - Insomnia: difficulty initiating sleep. - Dry mouth: reduced salivation. - Dyspepsia: indigestion or stomach discomfort.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations: visual or auditory disturbances. - Severe hypotension: marked blood pressure drop. - Cardiac arrhythmias: irregular heart rhythm. - Neuroleptic malignant syndrome: rare life‑threatening reaction.

When prescribing Levodopa + Benserazide, clinicians should consider several safety measures. - Dose titration: start low and increase gradually to minimize side effects. - Monitor blood pressure: watch for orthostatic hypotension, especially in the elderly. - Assess hepatic and renal function: adjust dosing if impairment is present. - Avoid abrupt discontinuation: taper to prevent withdrawal symptoms. - Use with caution in cardiac disease: risk of arrhythmias may be increased. - Store at room temperature: keep in the original pack, protect from moisture.

Levodopa + Benserazide can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: may cause hypertensive crisis. - Anticholinergic agents: can reduce antiparkinson efficacy. - Pyridoxine (vitamin B6): enhances peripheral levodopa metabolism, lowering central availability. - CNS depressants: additive sedation and dizziness.

Moderate Interactions (Monitor Closely): - Antihypertensives: may potentiate orthostatic hypotension. - Iron or calcium supplements: can decrease levodopa absorption. - High‑protein meals: compete for transport, reducing drug uptake.